Strides Pharma gets EIR for Singapore facility
2nd Apr 2019

Strides Pharma Science has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for Singapore facility, there by confirming the successful closure of the inspection which concluded on February 1, 2019. 

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.